Oncotelic Therapeutics, US6283411097

Oncotelic Therapeutics, US6283411097

23.11.2021 - 13:03:17

ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY

23.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Oncotelic Therapeutics

United States ISIN: US6283411097 EQS News ID: 1251370 ? End of News DGAP News Service

1251370??23.11.2021?

@ dgap.de